Phase (Ph) I/II study of MBG453 +/- spartalizumab (PDR001) in patients (pts) with advanced malignancies

Curigliano, G; Gelderblom, H; Mach, N; Doi, T; Tai, WMD; Forde, P; Sarantopoulos, J; Bedard, PL; Lin, CC; Hodi, S; Wilgenhof, S; Santoro, A; Sabatos-Peyton, C; Longmire, T; Wan, K; Nikolopoulos, P; Manenti, L; Naing, A

CANCER RESEARCH, 2019; 79 (13):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索